Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Viral Regulation of RIPK3: Implications for Cell Death in In
2026-06-04
This study identifies a class of viral proteins (vIRD) in orthopoxviruses that induce proteasomal degradation of the necroptosis adaptor RIPK3, thereby modulating virus-induced inflammation and pathogenesis. These findings clarify how viruses manipulate necroptotic and apoptotic pathways, offering mechanistic insights relevant to both virology and programmed cell death research.
-
LINC02870 Drives SNAIL Translation in Hepatocellular Carcino
2026-06-04
This study elucidates how the long non-coding RNA LINC02870 promotes hepatocellular carcinoma (HCC) progression by enhancing SNAIL translation through interaction with EIF4G1. The findings provide mechanistic insight into lncRNA-mediated translational control in HBV-related HCC, offering new avenues for biomarker discovery and therapeutic targeting.
-
OTUD3 Stabilizes SLC7A11 to Drive Sunitinib Resistance in cc
2026-06-03
This study identifies OTUD3 as a critical regulator of sunitinib resistance in clear cell renal cell carcinoma (ccRCC) through stabilization of SLC7A11 and suppression of ferroptosis. These findings provide a mechanistic rationale for targeting OTUD3 to improve therapeutic outcomes in ccRCC.
-
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody: Workflow and QC Gui
2026-06-03
The Cy3 Goat Anti-Rabbit IgG (H+L) Antibody addresses the need for sensitive, specific detection of rabbit IgG in immunofluorescence, immunohistochemistry, and related assays. It is suitable for workflows requiring robust signal amplification but should not be used in diagnostic or clinical applications.
-
DMG-PEG2000-NH2 in Next-Gen Amide Linkage for Lipid Nanocarr
2026-06-02
Explore the scientific underpinnings of DMG-PEG2000-NH2 as a NH2-PEG derivative for advanced lipid nanoparticle and liposomal drug delivery. This article uniquely focuses on the linker’s amide bond formation dynamics, protocol-critical parameters, and lessons from recent antimicrobial optimization breakthroughs.
-
Forskolin: Catalyzing Translational Advances in cAMP Researc
2026-06-02
Explore how Forskolin, a benchmark adenylate cyclase activator, empowers translational researchers with mechanistic clarity and workflow robustness—spanning stem cell biology to disease modeling—while clarifying best practices for experimental reproducibility and clinical relevance.
-
Lycium barbarum Polysaccharide Activates AMPK/PINK1/Parkin M
2026-06-01
The reference study demonstrates that Lycium barbarum polysaccharide (LBP) alleviates high-fat-diet-induced skeletal muscle atrophy by activating the AMPK/PINK1/Parkin-mediated mitophagy pathway. This mechanistic insight highlights LBP's therapeutic potential in counteracting sarcopenic obesity and its associated metabolic dysfunctions.
-
Ionisable Lipid Variations Shape LNP Efficacy in mRNA Delive
2026-06-01
This study systematically investigates how variations in ionisable lipid and sterol composition affect the properties and biological performance of lipid nanoparticles (LNPs) for mRNA delivery. The findings clarify structure–function relationships critical for next-generation RNA therapeutics, emphasizing the pivotal role of ionisable lipid chemistry in both in vitro and in vivo contexts.
-
Testosterone Bounce as a Prognostic Biomarker in Prostate Ca
2026-05-31
Akakura et al. (2024) demonstrate that 'testosterone bounce,' defined as a transient serum testosterone increase above 20 ng/dL after nadir suppression with degarelix, predicts significantly improved overall and cancer-specific survival for prostate cancer patients. This introduces a robust, clinically relevant biomarker for outcome stratification during hormone therapy, expanding prognostic assessment beyond conventional PSA monitoring.
-
LINC02870 Promotes SNAIL Translation in Hepatocellular Carci
2026-05-30
The reference study unveils LINC02870 as a novel long non-coding RNA (lncRNA) that interacts with EIF4G1 to enhance SNAIL translation, thereby promoting hepatocellular carcinoma (HCC) progression. These findings offer mechanistic insight into HBV-related HCC metastasis and highlight potential molecular targets for therapeutic intervention.
-
GLT-1 Upregulation Mitigates TBI via CB1-CREB Pathway Suppre
2026-05-29
This study reveals that upregulation of GLT-1 in astrocytes attenuates neuronal apoptosis and cognitive dysfunction after traumatic brain injury (TBI) by inhibiting the CB1-CREB signaling pathway. The findings clarify the interplay between endocannabinoid signaling, glutamate homeostasis, and neuroprotection, providing a mechanistic basis for targeting these pathways in TBI models.
-
WZ4003: NUAK1/2 Inhibitor Workflows for Cancer & Tau Researc
2026-05-29
WZ4003 stands out as a precision NUAK1/2 inhibitor, enabling robust dissection of cell migration, proliferation, and tau phosphorylation in both cancer and neurodegenerative models. This guide delivers actionable protocols, troubleshooting insights, and a translation of reference study findings into practical assay strategies.
-
Tyrothricin Peptide Antibiotic Mixture: Optimizing Antimicro
2026-05-28
Tyrothricin, a broad-spectrum peptide antibiotic mixture, empowers researchers to dissect bacterial, fungal, and viral inhibition via membrane disruption. This guide details applied workflows, troubleshooting strategies, and practical innovations for maximizing Tyrothricin’s impact in infection and resistance studies.
-
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody: Technical Workflow
2026-05-28
The Cy3 Goat Anti-Rabbit IgG (H+L) Antibody enables sensitive and specific detection of rabbit-derived primary antibodies in immunofluorescence, IHC, ICC, and flow cytometry workflows. This product is designed for research-use only and should not be applied in clinical or diagnostic contexts. It is not suitable for detecting primary antibodies from non-rabbit species.
-
Biological Sex Influences Immune Response in Mouse mRNA Vacc
2026-05-27
This study demonstrates that while firefly luciferase mRNA expression is similar in male and female mice after LNP-mediated delivery, female mice mount significantly higher IgG responses. These findings underscore the necessity of incorporating biological sex as a variable in the design and interpretation of pre-clinical mRNA vaccine studies.